Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 2Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Muscle Invasive Bladder Urothelial Carcinoma 1Locally Advanced Rectal Carcinoma 1Gliosarcoma 1Glioma 1Genetic Diseases, Inborn 1Esophageal Neoplasms 1Circulating Tumor DNA 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

Circulating Tumor DNA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Circulating Tumor DNA × Circulating Tumor DNA × Clear all
NCT04555369 2021-07-19

The Value of ctDNA on Chemotherapy Efficacy for mCRC

Fudan University

Phase NA Unknown
300 enrolled

Circulating Tumor DNA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡